212 related articles for article (PubMed ID: 32713101)
1. Definitive-intent intensity modulated radiotherapy for modified-Adams' stage 4 canine sinonasal cancer: A retrospective study of 29 cases (2011-2017).
Stevens A; Turek M; Vail D; Christensen N; Forrest L
Vet Radiol Ultrasound; 2020 Nov; 61(6):718-725. PubMed ID: 32713101
[TBL] [Abstract][Full Text] [Related]
2. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016).
Gieger TL; Nolan MW
Vet Comp Oncol; 2018 Mar; 16(1):E68-E75. PubMed ID: 28741887
[TBL] [Abstract][Full Text] [Related]
3. Definitive-intent intensity-modulated radiation therapy provides similar outcomes to those previously published for definitive-intent three-dimensional conformal radiation therapy in dogs with primary brain tumors: A multi-institutional retrospective study.
Van Asselt N; Christensen N; Meier V; Rohrer Bley C; Laliberte S; Poirier VJ; Desai N; Chen Y; Turek M
Vet Radiol Ultrasound; 2020 Jul; 61(4):481-489. PubMed ID: 32356907
[TBL] [Abstract][Full Text] [Related]
4. Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas.
Fox-Alvarez S; Shiomitsu K; Lejeune AT; Szivek A; Kubicek L
Vet Radiol Ultrasound; 2020 May; 61(3):370-378. PubMed ID: 32189433
[TBL] [Abstract][Full Text] [Related]
5. Clinical-dosimetric relationship between lacrimal gland dose and keratoconjunctivitis sicca in dogs with sinonasal tumors treated with radiation therapy.
Poirier VJ; Matsuyama A; Kim C; Darko J; Fleck A
J Vet Intern Med; 2020 Mar; 34(2):867-872. PubMed ID: 32086981
[TBL] [Abstract][Full Text] [Related]
6. Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy.
Lawrence JA; Forrest LJ; Turek MM; Miller PE; Mackie TR; Jaradat HA; Vail DM; Dubielzig RR; Chappell R; Mehta MP
Vet Radiol Ultrasound; 2010; 51(5):561-70. PubMed ID: 20973393
[TBL] [Abstract][Full Text] [Related]
7. Nasal angiofibroma treatment outcome using intensity-modulated radiation therapy in a dog.
L Ashworth H; K Flesner B; J Norquest C; A Maitz C
Vet Radiol Ultrasound; 2021 Jul; 62(4):e40-e43. PubMed ID: 33634903
[TBL] [Abstract][Full Text] [Related]
8. A prospective pilot study on early toxicity from a simultaneously integrated boost technique for canine sinonasal tumours using image-guided intensity-modulated radiation therapy.
Soukup A; Meier V; Pot S; Voelter K; Rohrer Bley C
Vet Comp Oncol; 2018 Dec; 16(4):441-449. PubMed ID: 29761663
[TBL] [Abstract][Full Text] [Related]
9. Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors.
Glasser SA; Charney S; Dervisis NG; Witten MR; Ettinger S; Berg J; Joseph R
J Am Anim Hosp Assoc; 2014; 50(2):96-104. PubMed ID: 24446402
[TBL] [Abstract][Full Text] [Related]
10. Definitive-intent intensity-modulated radiation therapy for treatment of canine prostatic carcinoma: A multi-institutional retrospective study.
Walz JZ; Desai N; Van Asselt N; Poirier VJ; Hansen K; Selmic L
Vet Comp Oncol; 2020 Sep; 18(3):381-388. PubMed ID: 31811693
[TBL] [Abstract][Full Text] [Related]
11. Retrospective assessment of radiation toxicity from a definitive-intent, moderately hypofractionated image-guided intensity-modulated protocol for anal sac adenocarcinoma in dogs.
Körner M; Staudinger C; Meier V; Rohrer Bley C
Vet Comp Oncol; 2022 Mar; 20(1):8-19. PubMed ID: 33890343
[TBL] [Abstract][Full Text] [Related]
12. Dose-escalated simultaneously integrated boost radiation protocol fails to result in a survival advantage for sinonasal tumors in dogs.
Meier V; Staudinger C; Körner M; Soukup A; Rohrer Bley C
Vet Radiol Ultrasound; 2022 Sep; 63(5):633-648. PubMed ID: 35347801
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumor histology and computed tomographic staging for radiation treatment response of canine nasal tumors.
Adams WM; Kleiter MM; Thrall DE; Klauer JM; Forrest LJ; La Due TA; Havighurst TC
Vet Radiol Ultrasound; 2009; 50(3):330-5. PubMed ID: 19507402
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome in dogs with nasal tumors treated with intensity-modulated radiation therapy.
Hunley DW; Mauldin GN; Shiomitsu K; Mauldin GE
Can Vet J; 2010 Mar; 51(3):293-300. PubMed ID: 20514254
[TBL] [Abstract][Full Text] [Related]
15. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs.
Théon AP; Madewell BR; Harb MF; Dungworth DL
J Am Vet Med Assoc; 1993 May; 202(9):1469-75. PubMed ID: 8496103
[TBL] [Abstract][Full Text] [Related]
16. Changes in target volume during irradiation of canine intranasal tumors can significantly impact radiation dosimetry.
Yoshikawa H; Nolan MW
Vet Radiol Ultrasound; 2019 Sep; 60(5):594-604. PubMed ID: 31250950
[TBL] [Abstract][Full Text] [Related]
17. Short survival time following palliative-intent hypofractionated radiotherapy for non-resectable canine thyroid carcinoma: A retrospective analysis of 20 dogs.
Tsimbas K; Turek M; Christensen N; Vail DM; Forrest L
Vet Radiol Ultrasound; 2019 Jan; 60(1):93-99. PubMed ID: 30180282
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study of canine nasal tumor treated with hypofractionated radiotherapy.
Maruo T; Shida T; Fukuyama Y; Hosaka S; Noda M; Ito T; Sugiyama H; Ishikawa T; Madarame H
J Vet Med Sci; 2011 Feb; 73(2):193-7. PubMed ID: 20938105
[TBL] [Abstract][Full Text] [Related]
19. Safety and feasibility of stereotactic radiotherapy using computed portal radiography for canine intracranial tumors.
Rancilio NJ; Bentley RT; Plantenga JP; Parys MM; Crespo BG; Moore GE
Vet Radiol Ultrasound; 2018 Mar; 59(2):212-220. PubMed ID: 29205634
[TBL] [Abstract][Full Text] [Related]
20. Survival times for canine intranasal sarcomas treated with radiation therapy: 86 cases (1996-2011).
Sones E; Smith A; Schleis S; Brawner W; Almond G; Taylor K; Haney S; Wypij J; Keyerleber M; Arthur J; Hamilton T; Lawrence J; Gieger T; Sellon R; Wright Z
Vet Radiol Ultrasound; 2013; 54(2):194-201. PubMed ID: 23278974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
